Medicure Announces CFO Transition

Medicure Inc., a pharmaceutical company centered on the U.S. market, has announced a change in its financial leadership. Haaris Uddin, the current Chief Financial Officer, will step down from his position, with his resignation effective on July 24, 2026. Uddin plans to explore an opportunity in a different industry.

James Kinley, who previously served as Medicure's CFO from 2011 to 2021 and holds a position on the company's board, has been appointed as the interim CFO. He will take over following Uddin's departure. According to Dr. Albert D. Friesen, CEO and Chair of Medicure, the organization appreciates Uddin's contributions and is eager to welcome Kinley back to the leadership team.